G2-block after irradiation of cells with different p53 status
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
- MeSH
- dávka záření MeSH
- experimentální nádory metabolismus patologie radioterapie MeSH
- kontrolní body fáze G2 buněčného cyklu účinky záření MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nádorový supresorový protein p53 metabolismus MeSH
- viabilita buněk účinky záření MeSH
- vztah dávky záření a odpovědi MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- nádorový supresorový protein p53 MeSH
- TP53 protein, human MeSH Prohlížeč
BACKGROUND: Although it is clear that functional p53 is not required for radiation-induced G2 block, certain experimental findings suggest a role for p53 in this context. For instance, as we also confirm here, the maximum accumulation in the G2 compartment after X-ray exposure occurs much later in p53 mutants than in wild types. It remains to be seen, however, whether this difference is due to a longer block in the G2 phase itself. MATERIAL AND METHODS: We observed the movement of BrdU-labeled cells through G2 and M into G1. From an analysis of the fraction of labeled cells that entered the second posttreatment cell cycle, we were able to determine the absolute duration of the G2 and M phases in unirradiated and irradiated cells. RESULTS: Our experiments with four cell lines, two melanomas and two squamous carcinomas, showed that the radiation-induced delay of transition through the G2 and M phases did not correlate with p53 status. CONCLUSION: We conclude that looking at the accumulation of cells in the G2 compartment alone is misleading when differences in the G2 block are investigated and that the G2 block itself is indeed independent of functional p53.
Zobrazit více v PubMed
Int J Radiat Biol Relat Stud Phys Chem Med. 1978 Sep;34(3):285-90 PubMed
Int J Radiat Biol. 2004 Jan;80(1):53-63 PubMed
Oncogene. 2003 Sep 1;22(37):5774-83 PubMed
Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11 PubMed
Am J Clin Oncol. 2001 Oct;24(5):486-90 PubMed
Radiat Res. 2000 Dec;154(6):640-9 PubMed
Int J Radiat Biol. 1993 Jan;63(1):69-76 PubMed
Int J Radiat Biol. 2000 May;76(5):717-25 PubMed
Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8493-7 PubMed
Mol Biotechnol. 2006 Mar;32(3):227-48 PubMed
Radiat Res. 2001 Jan;155(1 Pt 1):50-6 PubMed
Int J Radiat Biol. 2000 Sep;76(9):1197-208 PubMed
Radiother Oncol. 1995 Oct;37(1):20-8 PubMed
Science. 1998 Nov 20;282(5393):1497-501 PubMed
Oncogene. 2001 Apr 5;20(15):1803-15 PubMed
Oncogene. 1995 Jan 5;10(1):109-15 PubMed
Cell Cycle. 2011 Mar 1;10(5):819-29 PubMed
Crit Rev Biochem Mol Biol. 2011 Aug;46(4):271-83 PubMed